BIOMAT Database Logo BIOMAT Database Logo

Rescue therapy with once-daily atazanavir-based regimens for antiretroviral-experienced HIV-infected patients. 2006

Fernando Dronda, and Antonio Antela, and María J Pérez-Elías, and José L Casado, and Ana Moreno, and Santiago Moreno

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069446 Atazanavir Sulfate An azapeptide and HIV-PROTEASE INHIBITOR that is used in the treatment of HIV INFECTIONS and AIDS in combination with other ANTI-HIV AGENTS. 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester,Atazanavir,BMS 232632,BMS-232632,BMS-232632-05,BMS232632,CGP 73547,CGP 75136,CGP 75176,CGP 75355,CGP-73547,CGP-75136,CGP-75176,CGP-75355,CGP75136,CGP75176,CGP75355,Reyataz,232632, BMS,BMS 232632 05,BMS23263205,CGP73547
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Fernando Dronda, and Antonio Antela, and María J Pérez-Elías, and José L Casado, and Ana Moreno, and Santiago Moreno
Antiretroviral Therapy for HIV Infection: Time to Switch to Once-Daily Regimens?
August 2015, The Journal of the Association of Physicians of India,
Fernando Dronda, and Antonio Antela, and María J Pérez-Elías, and José L Casado, and Ana Moreno, and Santiago Moreno
[Rescue therapy with darunavir for treatment-experienced HIV-infected patients].
May 2016, Enfermedades infecciosas y microbiologia clinica,
Fernando Dronda, and Antonio Antela, and María J Pérez-Elías, and José L Casado, and Ana Moreno, and Santiago Moreno
Efficacy and safety of atazanavir, with or without ritonavir, as part of once-daily highly active antiretroviral therapy regimens in antiretroviral-naive patients.
February 2008, Journal of acquired immune deficiency syndromes (1999),
Fernando Dronda, and Antonio Antela, and María J Pérez-Elías, and José L Casado, and Ana Moreno, and Santiago Moreno
Antiretroviral regimens for treatment-experienced patients with HIV-1 infection.
April 2008, Expert opinion on pharmacotherapy,
Fernando Dronda, and Antonio Antela, and María J Pérez-Elías, and José L Casado, and Ana Moreno, and Santiago Moreno
Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in India.
February 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Fernando Dronda, and Antonio Antela, and María J Pérez-Elías, and José L Casado, and Ana Moreno, and Santiago Moreno
[Simplified HIV therapy. Atazanavir: the first protease inhibitor with once daily administration].
April 2004, MMW Fortschritte der Medizin,
Fernando Dronda, and Antonio Antela, and María J Pérez-Elías, and José L Casado, and Ana Moreno, and Santiago Moreno
Impact of acid-suppressive therapy on virologic response to atazanavir-based regimens in antiretroviral-experienced patients: a case series.
May 2005, Journal of acquired immune deficiency syndromes (1999),
Fernando Dronda, and Antonio Antela, and María J Pérez-Elías, and José L Casado, and Ana Moreno, and Santiago Moreno
Electrocardiographic changes in HIV-infected, drug experienced patients treated with atazanavir.
August 2008, AIDS (London, England),
Fernando Dronda, and Antonio Antela, and María J Pérez-Elías, and José L Casado, and Ana Moreno, and Santiago Moreno
Once-daily antiretroviral therapy in a cohort of HIV-infected children and adolescents.
October 2014, The Pediatric infectious disease journal,
Fernando Dronda, and Antonio Antela, and María J Pérez-Elías, and José L Casado, and Ana Moreno, and Santiago Moreno
Once-daily antiretroviral therapy among treatment-experienced Muslim patients fasting for the month of Ramadan.
October 2011, Tropical doctor,
Copied contents to your clipboard!